REMEGEN (09995) is recommended to adopt the A-share stock incentive plan in 2023.

19/11/2023

Connect global capital markets

REMEGEN (09995) announced that the board of directors recommends adopting the 2023 A-share stock incentive plan, planning to grant approximately 1.7831 million restricted stocks to the incentive beneficiaries. Upon the initial grant, 1.43245 million restricted stocks will be allocated, and approximately 0.3506 million restricted stocks will be reserved. The grant price (including reserved grants) is set at RMB 49.77 per A-share.

JIN MI FANG GP (08300) announced its annual performance with a shareholder's attributable loss of HK$3.515 million, compared to a decrease of 88.43% year-on-year.

CU VENTURE INV (08159) released its annual performance, with a net loss of 57.03 million Hong Kong dollars attributable to shareholders.

WAN LEADER (08482) released its annual performance, with a net loss of HKD 25.213 million, an increase of 2.2% year-on-year.

JIN MI FANG GP (08300) announced its annual performance with a shareholder's attributable loss of HK$3.515 million, compared to a decrease of 88.43% year-on-year.

CU VENTURE INV (08159) released its annual performance, with a net loss of 57.03 million Hong Kong dollars attributable to shareholders.

WAN LEADER (08482) released its annual performance, with a net loss of HKD 25.213 million, an increase of 2.2% year-on-year.